Clinical Trial Update: Sodium-glucose Transport 2 Inhibitors (SGLT2i) in HFrEF Patients [NA]

View source ↗

Summary

A completed clinical trial update assessing the use of sodium-glucose transport 2 inhibitors in patients with heart failure with reduced ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Damanhour University | Conditions: Heart Failure, Reduced Ejection Fraction Heart Failure | NA | Status: COMPLETED